Details for Patent: 8,486,947
✉ Email this page to a colleague
Which drugs does patent 8,486,947 protect, and when does it expire?
Patent 8,486,947 protects WAKIX and is included in one NDA.
This patent has thirty-four patent family members in twenty-six countries.
Summary for Patent: 8,486,947
| Title: | Treatment of Parkinson's disease, obstructive sleep apnea, dementia with Lewy bodies, vascular dementia with non-imidazole alkylamines histamine H.sub.3-receptor ligands |
| Abstract: | The present invention provides new method of treatment of Parkinson's disease, obstructive sleep apnea, narcolepsy, dementia with Lewy bodies, vascular dementia with non-imidazole alkylamine derivatives that constitute antagonists of the H.sub.3-receptors of histamine. |
| Inventor(s): | Schwartz; Jean-Charles (Paris, FR), Lecomte; Jeanne-Marie (Paris, FR) |
| Assignee: | Bioprojet (Paris, FR) |
| Application Number: | 11/909,778 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,486,947 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,486,947
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harmony | WAKIX | pitolisant hydrochloride | TABLET;ORAL | 211150-001 | Aug 14, 2019 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS WITH NARCOLEPSY | ⤷ Try a Trial | ||||
| Harmony | WAKIX | pitolisant hydrochloride | TABLET;ORAL | 211150-001 | Aug 14, 2019 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING CATAPLEXY IN PATIENTS WITH NARCOLEPSY | ⤷ Try a Trial | ||||
| Harmony | WAKIX | pitolisant hydrochloride | TABLET;ORAL | 211150-002 | Aug 14, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS WITH NARCOLEPSY | ⤷ Try a Trial | ||||
| Harmony | WAKIX | pitolisant hydrochloride | TABLET;ORAL | 211150-002 | Aug 14, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING CATAPLEXY IN PATIENTS WITH NARCOLEPSY | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,486,947
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 05290727 | Apr 1, 2005 | |
| PCT Information | |||
| PCT Filed | March 30, 2006 | PCT Application Number: | PCT/IB2006/000739 |
| PCT Publication Date: | October 05, 2006 | PCT Publication Number: | WO2006/103546 |
International Family Members for US Patent 8,486,947
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2006228413 | ⤷ Try a Trial | |||
| Brazil | PI0612216 | ⤷ Try a Trial | |||
| Canada | 2603656 | ⤷ Try a Trial | |||
| China | 101171009 | ⤷ Try a Trial | |||
| Cyprus | 1114636 | ⤷ Try a Trial | |||
| Denmark | 1863487 | ⤷ Try a Trial | |||
| Eurasian Patent Organization | 016007 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
